The Study of Efficacy and Mechanism in Fecal Microbiota Transplantation in the Treatment of Ulcerative Colitis

Jun Liu

Status and phase: Unknown; Phase 3; Phase 2

Conditions: Ulcerative Colitis; Fecal Microbiota Transplantation

Treatments: Biological: Fecal Microbiota Transplantation

Study type: Interventional

Funder types: Other

Identifiers

NCT02435160

20150406

Details and patient eligibility

About

The aim of our study is to investigate the efficacy and mechanism in fecal microbiota transplantation in the treatment of ulcerative colitis. About 20 Ulcerative Colitis (UC) patients will be recruited into our trial for Fecal Microbiota Transplantation (FMT) treatment,the safety and efficacy of FMT will be observed.

Enrollment: 20 estimated patients

Sex: Male

Ages: 25 to 60 years old

Volunteers: No Healthy Volunteers

Inclusion criteria

• mild to moderate UC patients
• male
• volunteered to our FMT trial

Exclusion criteria

• severe UC
• Hb < 6g/dL

Trial design

Primary purpose: Treatment

Allocation: N/A

Interventional model: Single Group Assignment

Masking: None (Open label)

---

20 participants in 1 patient group

Ulcerative Colitis

Experimental group

Treatment:

Biological: Fecal Microbiota Transplantation